Opdualag (Nivolumab-Relatlimab), for the Treatment of Melanoma
Drug Info: ApoThera Drug Disease Clinical Support App Melanoma Unresectable or Metastatic - 480mg/160mg IV every 4 weeks - Continue until disease progression or unacceptable toxicity occurs Infusion-related Reactions Grade…
